Advances in renal cell carcinoma treatment
Marc‐Oliver Grimm(Klinik und Poliklinik für Urologie), Manfred P. Wirth(University Hospital Carl Gustav Carus), M. Fröhner(Technische Universität Dresden), Stefan Zastrow(University Hospital Carl Gustav Carus), Ingmar Wolff(Universitätsmedizin Greifswald)
Cited by 26
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women
|Osteoporosis International|1999|594
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386